Equine Herpesvirus 1 and 4 Respiratory Disease in the Horse

Wendy Harless, Nicola Pusterla

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Equine herpesvirus (EHV)-1 and -4 associated respiratory disease in the horse occurs worldwide. Clinically there are no distinguishing characteristics between EHV-1 and EHV-4 infection. Disease is spread between animals by aerosolized virus, direct contact with infected respiratory secretions, or fomites. Diagnosis can be made by virus isolation, PCR of nasopharyngeal secretions or peripheral blood mononuclear cells, or serology. The characteristics of the protective immune response against EHV-1/4 infection have not been well described, but it is likely a combination of humoral and cell-mediated immunity. Current vaccines stimulate primarily a humoral immune response, which may decrease the severity of clinical signs, viremia, and viral shedding, but does not provide protection from infection. Since suckling foals have recently been shown to be an important reservoir in the transmission of EHV-1 and EHV-4, they ought to be the target for immunoprophylaxis to eliminate or significantly reduce EHV infections in the field and prevent the establishment of a latent state. Until more effective vaccine strategies are developed, appropriate herd management is essential to preventing or containing outbreaks of EHV-1/4.

Original languageEnglish (US)
Pages (from-to)197-202
Number of pages6
JournalClinical Techniques in Equine Practice
Volume5
Issue number3
DOIs
StatePublished - Sep 2006

Fingerprint

Equid Herpesvirus 4
Equid Herpesvirus 1
Equid herpesvirus 4
Horse Diseases
Equid herpesvirus 1
respiratory tract diseases
horses
Herpesviridae Infections
Fomites
Vaccines
fomites
secretion
infection
vaccines
Viruses
Virus Shedding
viruses
viral shedding
Viremia
viremia

Keywords

  • EHV-1
  • EHV-4
  • equine
  • respiratory disease

ASJC Scopus subject areas

  • Equine

Cite this

Equine Herpesvirus 1 and 4 Respiratory Disease in the Horse. / Harless, Wendy; Pusterla, Nicola.

In: Clinical Techniques in Equine Practice, Vol. 5, No. 3, 09.2006, p. 197-202.

Research output: Contribution to journalArticle

@article{9ab1d424e6e2408e82942cc30c2d9a98,
title = "Equine Herpesvirus 1 and 4 Respiratory Disease in the Horse",
abstract = "Equine herpesvirus (EHV)-1 and -4 associated respiratory disease in the horse occurs worldwide. Clinically there are no distinguishing characteristics between EHV-1 and EHV-4 infection. Disease is spread between animals by aerosolized virus, direct contact with infected respiratory secretions, or fomites. Diagnosis can be made by virus isolation, PCR of nasopharyngeal secretions or peripheral blood mononuclear cells, or serology. The characteristics of the protective immune response against EHV-1/4 infection have not been well described, but it is likely a combination of humoral and cell-mediated immunity. Current vaccines stimulate primarily a humoral immune response, which may decrease the severity of clinical signs, viremia, and viral shedding, but does not provide protection from infection. Since suckling foals have recently been shown to be an important reservoir in the transmission of EHV-1 and EHV-4, they ought to be the target for immunoprophylaxis to eliminate or significantly reduce EHV infections in the field and prevent the establishment of a latent state. Until more effective vaccine strategies are developed, appropriate herd management is essential to preventing or containing outbreaks of EHV-1/4.",
keywords = "EHV-1, EHV-4, equine, respiratory disease",
author = "Wendy Harless and Nicola Pusterla",
year = "2006",
month = "9",
doi = "10.1053/j.ctep.2006.03.014",
language = "English (US)",
volume = "5",
pages = "197--202",
journal = "Clinical Techniques in Equine Practice",
issn = "1534-7516",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Equine Herpesvirus 1 and 4 Respiratory Disease in the Horse

AU - Harless, Wendy

AU - Pusterla, Nicola

PY - 2006/9

Y1 - 2006/9

N2 - Equine herpesvirus (EHV)-1 and -4 associated respiratory disease in the horse occurs worldwide. Clinically there are no distinguishing characteristics between EHV-1 and EHV-4 infection. Disease is spread between animals by aerosolized virus, direct contact with infected respiratory secretions, or fomites. Diagnosis can be made by virus isolation, PCR of nasopharyngeal secretions or peripheral blood mononuclear cells, or serology. The characteristics of the protective immune response against EHV-1/4 infection have not been well described, but it is likely a combination of humoral and cell-mediated immunity. Current vaccines stimulate primarily a humoral immune response, which may decrease the severity of clinical signs, viremia, and viral shedding, but does not provide protection from infection. Since suckling foals have recently been shown to be an important reservoir in the transmission of EHV-1 and EHV-4, they ought to be the target for immunoprophylaxis to eliminate or significantly reduce EHV infections in the field and prevent the establishment of a latent state. Until more effective vaccine strategies are developed, appropriate herd management is essential to preventing or containing outbreaks of EHV-1/4.

AB - Equine herpesvirus (EHV)-1 and -4 associated respiratory disease in the horse occurs worldwide. Clinically there are no distinguishing characteristics between EHV-1 and EHV-4 infection. Disease is spread between animals by aerosolized virus, direct contact with infected respiratory secretions, or fomites. Diagnosis can be made by virus isolation, PCR of nasopharyngeal secretions or peripheral blood mononuclear cells, or serology. The characteristics of the protective immune response against EHV-1/4 infection have not been well described, but it is likely a combination of humoral and cell-mediated immunity. Current vaccines stimulate primarily a humoral immune response, which may decrease the severity of clinical signs, viremia, and viral shedding, but does not provide protection from infection. Since suckling foals have recently been shown to be an important reservoir in the transmission of EHV-1 and EHV-4, they ought to be the target for immunoprophylaxis to eliminate or significantly reduce EHV infections in the field and prevent the establishment of a latent state. Until more effective vaccine strategies are developed, appropriate herd management is essential to preventing or containing outbreaks of EHV-1/4.

KW - EHV-1

KW - EHV-4

KW - equine

KW - respiratory disease

UR - http://www.scopus.com/inward/record.url?scp=33747351337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747351337&partnerID=8YFLogxK

U2 - 10.1053/j.ctep.2006.03.014

DO - 10.1053/j.ctep.2006.03.014

M3 - Article

AN - SCOPUS:33747351337

VL - 5

SP - 197

EP - 202

JO - Clinical Techniques in Equine Practice

JF - Clinical Techniques in Equine Practice

SN - 1534-7516

IS - 3

ER -